124 related articles for article (PubMed ID: 37147968)
21. Adjuvant therapy for early endometrial cancer - who benefits the most from a radiation therapy?
Michalak M; Warenczak Florczak Z; Staszewska-Nowak A; Roszak A
Ginekol Pol; 2020; 91(1):6-12. PubMed ID: 32039461
[TBL] [Abstract][Full Text] [Related]
22. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
[TBL] [Abstract][Full Text] [Related]
23. Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study.
Ørtoft G; Høgdall C; Juhl C; Petersen LK; Hansen ES; Dueholm M
Int J Gynecol Cancer; 2019 Mar; 29(3):497-504. PubMed ID: 30833438
[TBL] [Abstract][Full Text] [Related]
24. Increased risk of recurrence in early-stage endometrial carcinoma after delays in adjuvant radiation treatment.
Zhu S; Khalil R; Altairy O; Burmeister C; Dimitrova I; Elshaikh M
Int J Gynecol Cancer; 2021 Jan; 31(1):73-77. PubMed ID: 33087415
[TBL] [Abstract][Full Text] [Related]
25. Mucinous adenocarcinoma of the endometrium: case series and review of the literature.
Jalloul RJ; Elshaikh MA; Ali-Fehmi R; Haley MM; Yoon J; Mahan M; Munkarah AR
Int J Gynecol Cancer; 2012 Jun; 22(5):812-8. PubMed ID: 22569105
[TBL] [Abstract][Full Text] [Related]
26. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
[TBL] [Abstract][Full Text] [Related]
27. Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.
Francis SR; Ager BJ; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
Gynecol Oncol; 2019 Jul; 154(1):38-44. PubMed ID: 31029507
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
29. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study.
Ørtoft G; Høgdall C; Hansen ES; Dueholm M
J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: an Italian multicenter retrospective study (CTF study).
Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Sostegni B; Bellicini A; Fuso L; Cristofani R; Sartori E
Gynecol Oncol; 2014 Jul; 134(1):29-35. PubMed ID: 24769176
[TBL] [Abstract][Full Text] [Related]
31. Vaginal and pelvic recurrences in stage I and II endometrial carcinoma--survival and prognostic factors.
Blecharz P; Brandys P; Urbański K; Reinfuss M; Patla A
Eur J Gynaecol Oncol; 2011; 32(4):403-7. PubMed ID: 21941962
[TBL] [Abstract][Full Text] [Related]
32. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
[TBL] [Abstract][Full Text] [Related]
33. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
34. Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model.
Ren K; Wang W; Sun S; Hou X; Hu K; Zhang F
Cancer Med; 2022 Jan; 11(1):257-267. PubMed ID: 34779587
[TBL] [Abstract][Full Text] [Related]
35. Is there any benefit of paraaortic field irradiation in pelvic lymph node positive endometrial cancer patients? A propensity match analysis.
Onal C; Yuce Sari S; Akkus Yildirim B; Gultekin M; Guler OC; Yildiz F
J Obstet Gynaecol; 2020 Oct; 40(7):1012-1019. PubMed ID: 31793400
[TBL] [Abstract][Full Text] [Related]
36. Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer.
Philp L; Tannenbaum S; Haber H; Saini A; Laurent JS; James K; Feltmate CM; Russo AL; Growdon WB
Gynecol Oncol; 2021 Feb; 160(2):389-395. PubMed ID: 33358198
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant chemoradiotherapy vs. radiotherapy alone in early-stage high-risk endometrial cancer: a systematic review and meta-analysis.
Jingjing H; Rui J; Hui P
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):833-840. PubMed ID: 30720192
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant radiation in early stage, unfavorable histology endometrial carcinoma is associated with improved local control and survival.
Ly D; Rowley BD; Dodson MK; Soisson PA; Jolles CJ; Gaffney DK; Sause WT
Gynecol Oncol; 2014 May; 133(2):250-5. PubMed ID: 24589416
[TBL] [Abstract][Full Text] [Related]
39. Significant pelvic recurrence in high-risk pathologic stage I--IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy.
Mundt AJ; McBride R; Rotmensch J; Waggoner SE; Yamada SD; Connell PP
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1145-53. PubMed ID: 11483323
[TBL] [Abstract][Full Text] [Related]
40. Analysis of outcome of Stage I-III endometrial cancer treated with systematic operation omitting paraaortic lymphadenectomy.
Kyo S; Hashimoto M; Maida Y; Mizumoto Y; Nakamura M; Takakura M; Inoue M
Eur J Gynaecol Oncol; 2007; 28(3):170-3. PubMed ID: 17624080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
